ClinicalTrials.gg
TerminatedNCT05863884Updated Nov 13, 2026Results posted

RADx-UP- Impact of Community Health Worker Deployment

An interventional study of Impact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake in Diabetes, COVID-19 and Community Health Workers, sponsored by Morehouse School of Medicine. Terminated at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Morehouse School of Medicine · Not applicable, Interventional, and Prevention

How we know

Why this study was terminated
The study stopped due to staffing challenges.

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Feb 2022, registered Dec 2022).
Updated Nov 13, 2026Now TerminatedResults posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 3,023 studies in Diabetes Mellitus with a site in United States — 289 open to participants now, 388 under way, 12 of them phase 3. Diabetes Mellitus · United States.

Enrollment
1,779th of 2,502
33 · median 82
Started
2022
with 91 others
No phase
1,418 of 3,023
159 open now
Registered
2,667th of 3,023
by date

Among the 3,023 studies in Diabetes Mellitus with a site in United States, this one is the 1,779th largest by enrollment of the 2,502 interventional ones that give a count, is one of 92 that started in 2022, is one of 1,418 with no phase, and was the 2,667th registered.

Diabetes Mellitus

8,295 studies on the registry are indexed under Diabetes Mellitus; 1,071 are open to participants now.

Browse Diabetes Mellitus studies →

Open to participants now

289 of the 3,023 studies in Diabetes Mellitus with a site in United States are open now. Recruiting first, the newest first:

284 more — sign in →

All 289 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 649 Diabetes Mellitus studies recruiting now, 358 (55%) set no upper age limit and 194 (30%) stop at 75 or younger; 89 take children under 18; 181 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 3,023 studies in Diabetes Mellitus with a site in United States, or all of them as a file.
02

Study summary

The proposed project will implement and evaluate a brief Community Health Worker (CHW) intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC). The primary goal of this study is to maximize effective outreach, education, and communication through CHWs in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable communities. CHWs will be deployed to the homes of adults with increased risk of morbidity and mortality (i.e., African Americans or Latinos with uncontrolled diabetes or prediabetes, age \<50 years, and non-COVID-19 vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments, including blood glucose measurement, will be conducted on the indexed patient and offered to all other adult family members in the household (i.e., "bubble"). Adults with Type 2 diabetes likely live in households with other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity).1 It is expected that they will also share similar COVID-19 exposure risk. The specific aims are to: 1) Evaluate a community-driven education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with uncontrolled diabetes and their families (i.e., their "bubble") and 2) Evaluate a community-driven education program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in individuals with uncontrolled diabetes in rural, Southwest Georgia.

03

Conditions studied

  • Diabetes
  • COVID-19
  • Community Health Workers
  • Health Behavior
  • Health Knowledge, Attitudes, Practice

Keywords

  • diabetes
  • COVID-19
  • rural communities
  • rural health center
  • rural population
  • community health workers
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be between18 and 50 years
  • Self-identify as African American/Black or Latino
  • English speaking
  • Have received care for uncontrolled diabetes ( > 9%) or prediabetes diagnosis within one of the AAPHC 27 community sites
  • Unvaccinated for Phase 1 (vaccinated for Phase 2)

Exclusion criteria

Exclusion Criteria:

  • Not meeting the Inclusion Criteria
  • Enrolled in the parent RADx-UP Project PEACH study
  • Unable or unwilling to provide to participate in the study (ie: incarcerated individuals and children)
  • Individuals with a terminal cancer diagnosis, have chronic kidney disease (stage 4-5), pregnant women, and people with severe psychological disorders (i.e., dementia,suicide ideation)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • Other
    CHW Intervention

    A six week CHW home-visit behavioral intervention examining changes in diabetes outcomes.

    Behavioral: Impact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake

Interventions

  • BehavioralImpact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake

    CHWs will conduct home visits to provide diabetes and COVID-19 health education based on the participant's needs, interests, and clinical health assessment results. All adults in the household will be invited to participate in the health education discussions. At each visit, the CHW will use diabetes management and COVID-19 educational materials to facilitate and inform discussions. CHWs will also make available at-home COVID-19 testing kits with instructions for the patient and their household family members. The discussion of COVID-19 beliefs, perceptions, and related behaviors will be raised during a later visit, i.e., after rapport and trust has been established and if it has not been raised by the participants during the earlier visits. In addition, CHWs will help schedule vaccination and healthcare appointments upon participant's interest.

06

What researchers measure

Primary outcomes

  1. HbA1c Level

    Mean change in HbA1c levels from baseline (week 1) to week 6.

    Time frame: 6 weeks

07

Results

Posted Nov 13, 2026
Limitations and caveats
Early study termination resulted in a small number of subjects being analyzed due to challenges with recruiting and retaining community health worker staff. In addition, technical difficulties with community health worker staff learning to use data management software (i.e., REDCap and Excel) for data entry delayed data uploads. The unexpected death of a community health worker also contributed to missing participant clinical assessment data..

Participant flow

AAPHC sent automated study invitations through its electronic medical record (EMR) system to patients who met the study eligibility criteria. Invitations were distributed through the patient portal, email, text messages, and automated phone calls. Following the EMR outreach, community health workers contacted eligible participants using the EMR-generated report to invite them to enroll in the intervention. Recruitment lasted for 18 months.

Participant flow — Overall Study
MilestoneCHW Intervention
Started33
Completed29
Not completed4

Outcome measures

PrimaryHbA1c Level

Mean change in HbA1c levels from baseline (week 1) to week 6.

Time frame:
6 weeks
Reported as:
Mean · mmol/mol
HbA1c Level
mmol/molCHW Intervention
HbA1c Level-.01 (-0.65 to 0.62)

Adverse events

Collected over 0. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CHW Intervention———

Baseline characteristics

Attrition during the study contributed to lower number of participants at study completion.

Age, Customized
Age, Customized(years)CHW Intervention
Average of study participants age (mean, std dev.)40.71 ± 8.02
Sex: Female, Male
Sex: Female, Male(Participants)CHW Intervention
Female24
Male9
Race (NIH/OMB)
Race (NIH/OMB)(Participants)CHW Intervention
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American33
White0
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)CHW Intervention
United States33
08

Study locations

1 site
  • Albany Area Primary Health Care
    Albany, Georgia 31707, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2022 to primary completion in Nov 2024, 33 months.

Results were first posted in Nov 2026, 1 year 11 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 2, 2022
First posted
May 18, 2023
StartActual
Feb 11, 2022
Primary completionActual
Nov 30, 2024
CompletionActual
Apr 30, 2025
Results first posted
Nov 13, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Completed→Terminated The study stopped due to staffing challenges.
changed Nov 13, 2026
Results
Results posted
posted Nov 13, 2026
Enrollment
87→33
Nov 13, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Blood Glucose LevelNow HbA1c LevelTime frame: 6 weeks
Nov 13, 2026
Documents
Secondary outcomes
2 removed
What changed in the outcomes
  • RemovedDiabetes Self-Management ScoreTime frame: 6 weeks
  • Removedother outcomeCOVID-19 Vaccination Confidence and UptakeTime frame: 6 weeks
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Completed→Terminated
    Why stopped The study stopped due to staffing challenges.
    Results posted
    Enrollment 87→33
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Blood Glucose LevelNow HbA1c LevelTime frame: 6 weeks
    Secondary outcomes 2 removed
    What changed in the outcomes
    • RemovedDiabetes Self-Management ScoreTime frame: 6 weeks
    • Removedother outcomeCOVID-19 Vaccination Confidence and UptakeTime frame: 6 weeks
    + 7 other changes: index terms, identifiers, verification date, responsible party, oversight details, data sharing statement and registry notes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05863884
Lead sponsor
Morehouse School of Medicine
Responsible party
Sponsor
First posted
May 18, 2023
Start date
Feb 11, 2022
Primary completion
Nov 30, 2024
Completion
Apr 30, 2025
Results posted
Nov 13, 2026
Last update
Nov 13, 2026

Study contacts

Rakale C Quarells, PhD
principal investigator · Morehouse School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion